Albion Human Nutrition is now a Cornerstone Sponsor of Vitamin Angels.
Westchester, IL-based Ingredion Inc. published a white paper called, “A Revolutionary Starch Emulsifier for Maximized Beverage Emulsion Productivity.” The emulsifier lets beverage makers deliver “both flavor (or color) and turbidity effectively, allowing [them] to maximize oil load and minimize water usage in emulsion concentrates for significant savings.” For a copy, contact Ingredion at e-mail email@example.com or visit www.ingredion.us/specialties.
innoVactiv of Rimouski, QC, Canada, now has two allowable health claims from the Natural Health Product Directorate of Health Canada for its InSea2 ingredient. They are: “Helps support healthy blood glucose levels” and “Helps reduce the glycemic index of ingested foods.”
Nutraceutix of Redmond, WA announced that it has new patents from the Japanese Patent Office and the Canadian Patent Office for its probiotic delivery technology.
A randomized crossover clinical study published in Phytotherapy Research found that Sabinsa’s Curcumin C3 Complex caused a reduction in triglyceride levels. The firm is based in East Windsor, NJ.
The Canadian Intellectual Property Office gave INO’Réal SA of Plérin, France and P.L. Thomas & Co., Inc. a patent for the use of saffron, the saffron extracts crocin and picrocrocin, and their derivatives that are satiety agents.
Sunsweet Growers will develop functional beverages that contain HIDROX, a hydroxytyrosol-rich ingredient from organic olives marketed by CreAgri of Hayward, CA.
Naturex of Avignon, France has acquired cranberry expert Decas Botanical Synergies of Carver, MA.
AIDP, Inc. of City of Industry, CA was awarded a patent for Magtein’s “Magnesium compositions and uses thereof for metabolic disorders” (Patent 8,163,301).
The September 2012 issue of International Journal of Medical Sciences published a meta-analysis of 20 studies that concluded, “bitter orange extract and p-synephrine increase metabolism and energy expenditure,” “when taken for periods of time up to 12 weeks may result in modest weight loss” and “p-synephrine alone or in combination with caffeine does not appear to produce significant adverse cardiovascular effects or pose a risk to human health at doses commonly ingested orally.” The study was written by Sidney J. Stohs, Ph.D., Harry G. Preuss, M.D., and Mohd Shara, Pharm.D., Ph.D.
Published in WholeFoods Magazine, November 2012